MDT

87.93

+1.17%↑

VEEV

281.03

-0.66%↓

A

119.21

+0.2%↑

HQY

103.63

-1.89%↓

PHR.US

28.29

+0.07%↑

MDT

87.93

+1.17%↑

VEEV

281.03

-0.66%↓

A

119.21

+0.2%↑

HQY

103.63

-1.89%↓

PHR.US

28.29

+0.07%↑

MDT

87.93

+1.17%↑

VEEV

281.03

-0.66%↓

A

119.21

+0.2%↑

HQY

103.63

-1.89%↓

PHR.US

28.29

+0.07%↑

MDT

87.93

+1.17%↑

VEEV

281.03

-0.66%↓

A

119.21

+0.2%↑

HQY

103.63

-1.89%↓

PHR.US

28.29

+0.07%↑

MDT

87.93

+1.17%↑

VEEV

281.03

-0.66%↓

A

119.21

+0.2%↑

HQY

103.63

-1.89%↓

PHR.US

28.29

+0.07%↑

Search

Codexis Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

2.39 -0.42

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.33

Max

2.46

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-10M

-21M

Pardavimai

-14M

7.5M

Pelnas, tenkantis vienai akcijai

-0.25

Pelno marža

-274.268

Darbuotojai

188

EBITDA

-11M

-20M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+140.98% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-24M

195M

Ankstesnė atidarymo kaina

2.81

Ankstesnė uždarymo kaina

2.39

Naujienos nuotaikos

By Acuity

50%

50%

164 / 380 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Codexis Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-30 21:26; UTC

Pagrindinės rinkos jėgos

AeroVironment Shares Slide on Stock, Notes Offerings

2025-06-30 16:50; UTC

Įsigijimai, susijungimai, perėmimai

BBVA Won't Withdraw Sabadell Offer

2025-06-30 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher, Underpinned by Fed-Rate Cut Hopes -- Market Talk

2025-06-30 23:38; UTC

Rinkos pokalbiai

Nikkei May Fall as Yen Has Strengthened Amid Trade Uncertainty -- Market Talk

2025-06-30 23:38; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-06-30 23:03; UTC

Uždarbis

Boeing CFO Exit Is Latest Change in Chief Executive Kelly Ortberg's C-Suite -- Update

2025-06-30 22:50; UTC

Įsigijimai, susijungimai, perėmimai

Giant Eagle Closes Sale of Its GetGo Business to Alimentation Couche-Tard

2025-06-30 22:50; UTC

Uždarbis

Boeing Hires Former Lockheed Martin Executive to Succeed CFO Brian West -- Update

2025-06-30 21:26; UTC

Uždarbis

Berkshire Stock Ends Quarter on Sour Note. It's About Even With S&P 500 So Far in 2025. -- Barrons.com

2025-06-30 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-06-30 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-30 19:46; UTC

Rinkos pokalbiai

Nike's Buzz is Back Amid Lean into Women Sports -- Market Talk

2025-06-30 19:16; UTC

Rinkos pokalbiai

Oil Futures Snap Winning Streak on OPEC+ Outlook -- Market Talk

2025-06-30 19:10; UTC

Rinkos pokalbiai

U.S. Natural Gas Wipes Out Friday's Gains -- Market Talk

2025-06-30 19:07; UTC

Rinkos pokalbiai

Dollar Ends Losing Quarter Facing Downward Pressure -- Market Talk

2025-06-30 18:27; UTC

Rinkos pokalbiai

Gold Has Largest Half-Year Gain Since 2007 -- Market Talk

2025-06-30 17:08; UTC

Įsigijimai, susijungimai, perėmimai

MicroStrategy Stock Jumps After Latest Bitcoin Purchase as Holdings Near 600,000 Tokens -- Barrons.com

2025-06-30 17:00; UTC

Įsigijimai, susijungimai, perėmimai

HPE Stock Soars as Juniper Merger Gets Regulatory Approval. There's Just 1 Catch. -- Barrons.com

2025-06-30 16:41; UTC

Rinkos pokalbiai

WTI Crude Undeperforms as U.S.-Canada Trade Talks to Resume -- Market Talk

2025-06-30 16:32; UTC

Rinkos pokalbiai

United Parks' Potential Buyback Resumption Could Be Catalyst For Stock -- Market Talk

2025-06-30 16:23; UTC

Įsigijimai, susijungimai, perėmimai

BBVA: Offer Remains in Effect in Accordance With Applicable Regulations

2025-06-30 16:22; UTC

Įsigijimai, susijungimai, perėmimai

BBVA Decided Not to Withdraw Offer for Banco De Sabadell

2025-06-30 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-06-30 16:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-06-30 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-06-30 16:07; UTC

Uždarbis

Umicore to Post 1H Results on Aug 1

2025-06-30 15:59; UTC

Rinkos pokalbiai

Copper Conditions Set to Remain Tight But Risks Loom -- Market Talk

2025-06-30 15:55; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Home Depot to Consolidate Pro Distribution with GMS Deal -- Market Talk

2025-06-30 15:54; UTC

Rinkos pokalbiai

Gold Futures Recoup Some Losses Though Demand Looks Set to Weaken -- Market Talk

2025-06-30 15:41; UTC

Įsigijimai, susijungimai, perėmimai

Google Bets Big on Nuclear Fusion With MIT Spinoff Commonwealth -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Codexis Inc Prognozė

Kainos tikslas

By TipRanks

140.98% į viršų

12 mėnesių prognozė

Vidutinis 5.88 USD  140.98%

Aukščiausias 11 USD

Žemiausias 3 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Codexis Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

4

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

2.25 / 2.53Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

164 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.